# Marinus Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/marinus-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Radnor, US
- Website: www.marinuspharma.com
- Total disclosed funding: $71M
- Latest round: Series C (Jan 7, 2013)
- Investors on record: 5

## About

Based in Pennsylvania, US, and founded in 2003, Marinus Pharmaceuticals, Inc. operates as a pharmaceutical manufacturing company that develops treatments for neurological and psychiatric disorders like status epilepticus, tuberous sclerosis complex, and CDKL5 deficiency disorder. In March 2022, Marinus Pharmaceuticals, Inc. raised USD 30 million in venture debt financing led by Oaktree Capital Management. As of November 2022, Scott Braunstein, M.D. is the Chief Executive Officer (CEO) of the company. 

Marinus Pharmaceuticals, Inc. focused on the development of new treatments for epilepsy and neuropsychiatric disorders and improves the treatment methodology for patients by developing the treatment of Status Epilepticus (SE), CDKL5 Deficiency Disorder (CDD), Tuberous Sclerosis Complex (TSC), and PCDH19 pediatric epilepsy. 

The company plans to use March 2022 funds for ZTALMY® (ganaxolone) oral suspension for the treatment of seizures associated with CDKL5 deficiency  (CDD) in patients 2 years of age and older.

## Funding rounds

- Series C, Jan 7, 2013, $9.8M — Domain Associates, Sofinnova Investments, Canaan Partners, Foundation Medical Partners, RMI Partners
- Series C, Dec 3, 2012, $11M — Domain Associates, Sofinnova Investments, Canaan Partners, Foundation Medical Partners, RMI Partners
- Series B, Apr 10, 2009, $20M — Domain Associates, Sofinnova Investments, Canaan Partners, Foundation Medical Partners
- Series A, Oct 25, 2005, $29M — Domain Associates, Sofinnova Investments, Canaan Partners, Foundation Medical Partners

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A, Series B, Series C
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A, Series B, Series C
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A, Series B, Series C
- Foundation Medical Partners (https://capitalatlas.ai/funds/foundation-medical-partners) — Series A, Series B, Series C
- RMI Partners (https://capitalatlas.ai/funds/rmi-partners) — Series C